Aurinia Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

CEO

Peter S. Greenleaf

CEOPeter S. Greenleaf

Employees

300

Employees300

Headquarters

Edmonton, Alberta

HeadquartersEdmonton, Alberta

Founded

1993

Founded1993

Employees

300

Employees300

AUPH Key Statistics

Market cap

741.17M

Market cap741.17M

Price-Earnings ratio

-9.26

Price-Earnings ratio-9.26

Dividend yield

—

Dividend yield—

Average volume

1.39M

Average volume1.39M

High today

$5.16

High today$5.16

Low today

$5.02

Low today$5.02

Open price

$5.02

Open price$5.02

Volume

471.78K

Volume471.78K

52 Week high

$12.43

52 Week high$12.43

52 Week low

$4.71

52 Week low$4.71

AUPH News

Seeking Alpha 5d

Aurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024 - Seeking Alpha

Editor's note: Seeking Alpha is proud to welcome Pivotal Biotech as a new contributing analyst. You can become one too! Share your best investment idea by submi...

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

37.5%

Sell